Tumor cell expression of CD59 is associated with resistance to CD20 serotherapy in B-cell malignancies.

被引：0
|
作者：
Treon, SP
Mitsiades, CS
Mitsiades, NS
Young, G
Doss, DS
Schlossman, RL
Anderson, KC
机构：
[1] Dana Farber Canc Inst, Dept Adult Oncol, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Dept Med, Boston, MA USA
来源：
BLOOD | 2000年 / 96卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
426
引用
收藏
页码：99A / 99A
页数：1
相关论文
共 50 条
  • [31] Diffuse large B-cell lymphoma, leg type with loss of CD20 expression
    Thomas, A.
    Cibull, T.
    O'Malley, D.
    Billings, S.
    [J]. JOURNAL OF CUTANEOUS PATHOLOGY, 2007, 34 (01) : 116 - 116
  • [32] Diagnostic significance of CD20 and FMC7 expression in B-cell disorders
    Delgado, J
    Matutes, E
    Morilla, AM
    Morilla, RM
    Owusu-Ankomah, KA
    Rafiq-Mohammed, F
    del Giudice, I
    Catovsky, D
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2003, 120 (05) : 754 - 759
  • [33] CD20 mutation is associated with resistance to rituximab in a subset of patients with B-cell non-Hodgkin lymphoma
    Libra, Massimo
    Terzo, Maria N.
    Militello, Loredana
    Russo, Alessia E.
    Ligresti, Giovanni
    Russo, Mario
    Nicoletti, Ferdinando
    Stivala, Franca
    Bonavida, Benjamin
    Travali, Salvatore
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2010, 26 : S66 - S66
  • [34] CD5-positive diffuse large B-cell lymphoma with an unusual phenotype: Cytoplasmic CD20(+), surface CD20(-)
    Yokose, Norio
    Shioi, Yumiko
    Sugisaki, Yuich
    Ohaki, Yoshiharu
    Ogata, Kiyoyuki
    Dan, Kazuo
    [J]. LEUKEMIA & LYMPHOMA, 2006, 47 (07) : 1415 - 1417
  • [35] An IgG1-like bispecific antibody targeting CD52 and CD20 for the treatment of B-cell malignancies
    Qi, Junpeng
    Chen, Shih-Shih
    Chiorazzi, Nicholas
    Rader, Christoph
    [J]. METHODS, 2019, 154 : 70 - 76
  • [36] Identification of CD19 and CD20 peptides for induction of antigen-specific CTLs against B-cell malignancies
    Bae, J
    Martinson, JA
    Klingemann, HG
    [J]. CLINICAL CANCER RESEARCH, 2005, 11 (04) : 1629 - 1638
  • [37] LOW-LEVEL CD20 EXPRESSION ON T-CELL MALIGNANCIES
    WARZYNSKI, MJ
    GRAHAM, DM
    AXTELL, RA
    ZAKEM, MH
    ROTMAN, RK
    [J]. CYTOMETRY, 1994, 18 (02): : 88 - 92
  • [38] Therapy of B-cell lymphoma with anti-CD20 antibodies can result in the loss of CD20 antigen expression
    Davis, TA
    Czerwinski, DK
    Levy, R
    [J]. CLINICAL CANCER RESEARCH, 1999, 5 (03) : 611 - 615
  • [39] Levels of expression of CD19 and CD20 in chronic B cell leukaemias
    Ginaldi, L
    De Martinis, M
    Matutes, E
    Farahat, N
    Morilla, R
    Catovsky, D
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 1998, 51 (05) : 364 - 369
  • [40] Novel combination immunochemotherapy beyond CD20 for B-cell lymphomas
    Yi, Jun Ho
    [J]. BLOOD RESEARCH, 2021, 56 : 1 - 4
12345